TY - JOUR
T1 - Bioadhesive polymeric nanoparticles as strategy to improve the treatment of yeast infections in oral cavity
T2 - in-vitro and ex-vivo studies
AU - Roque, Luís
AU - Castro, Pedro
AU - Molpeceres, Jesús
AU - Viana, Ana S.
AU - Roberto, Amílcar
AU - Reis, Cláudia
AU - Rijo, Patrícia
AU - Tho, Ingunn
AU - Sarmento, Bruno
AU - Reis, Catarina
N1 - Funding Information:
This research was supported by PADDIC scholarship. We thank our colleagues from Universidade Lusófona de Humanidades e Tecnologias who provided insight and expertise that greatly assisted the research. We also thank Ana Júlio for assistance with the permeation methodology.
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/7
Y1 - 2018/7
N2 - Candidiasis is by far the most common fungal infection in the oral cavity and locally antifungal drugs are generally considered the first line therapy. However, some antifungal drugs like Nystatin (Nys) have very short time in the target tissue, which generally it requires several daily applications. One of the solutions to overcome those issues could be the incorporation of Nys into small, protective and polymeric nanoparticles (NPs). In this work, unloaded NPs were prepared and fully characterized and implemented in toothpaste and an oral gel. The three-best unloaded system (smallest, stable, safe and bioadhesive) was selected for further studies. After loading, NPs presented a size range from 300 to 800 nm, high encapsulation efficiency (above 70%), prolonged release and high adhesion capacity to oral mucosa when compared with free Nys. Free Nys lost its activity when it was not encapsulated. The presented results suggested that these new bioadhesive systems could be considered as good candidates to improve the time residence of Nys in buccal mucosa, reducing the number of applications during the day, using alcohol free-formulations and easily included in the daily lives of the patients.
AB - Candidiasis is by far the most common fungal infection in the oral cavity and locally antifungal drugs are generally considered the first line therapy. However, some antifungal drugs like Nystatin (Nys) have very short time in the target tissue, which generally it requires several daily applications. One of the solutions to overcome those issues could be the incorporation of Nys into small, protective and polymeric nanoparticles (NPs). In this work, unloaded NPs were prepared and fully characterized and implemented in toothpaste and an oral gel. The three-best unloaded system (smallest, stable, safe and bioadhesive) was selected for further studies. After loading, NPs presented a size range from 300 to 800 nm, high encapsulation efficiency (above 70%), prolonged release and high adhesion capacity to oral mucosa when compared with free Nys. Free Nys lost its activity when it was not encapsulated. The presented results suggested that these new bioadhesive systems could be considered as good candidates to improve the time residence of Nys in buccal mucosa, reducing the number of applications during the day, using alcohol free-formulations and easily included in the daily lives of the patients.
KW - Antifungal drug
KW - Bioadhesion
KW - In vitro and ex-vivo studies
KW - Oral mucosa delivery
KW - Polymeric nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=85046657641&partnerID=8YFLogxK
U2 - 10.1016/j.eurpolymj.2018.04.032
DO - 10.1016/j.eurpolymj.2018.04.032
M3 - Article
AN - SCOPUS:85046657641
SN - 0014-3057
VL - 104
SP - 19
EP - 31
JO - European Polymer Journal
JF - European Polymer Journal
ER -